Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced its financial results for the second quarter of fiscal year 2025.

Samsung Galaxy Z Fold 7 breaks records in South Korea with strong pre-orders, outperforming Flip 7 for the first time.

The number of exchange-traded funds listed on South Korea’s capital market has surpassed 1,000, marking a key milestone in ...

The Galaxy Z Fold7 and Z Flip7 beat the record established by the Z Flip5 and Z Fold5 in 2023. The new foldables are off to a ...

A person quoted $100k for facial feminisation surgery flew 19 hours to South Korea - the 'plastic surgery capital of the ...

China’s giant BOE semiconductor and technology company is again suing South Korea-based Samsung over its use of BOE’s alleged OLED patents. The two business ...

Anaphite, a Bristol company whose dry coating technology cuts costs for battery manufacturers, has moved to strengthen its presence in South Korea.

South Korean EV charging network operator, Chaevi Company Ltd, has filed a preliminary application to list its shares on the Kosdaq.

According to the reports, Samsung Galaxy Z Fold 7 and Galaxy Z Flip 7 collectively achieved 1.04 million pre-orders in Korea. This is more than the previous record which was set at 1.02 million in ...

A key aim of South Korean government policy for startups is to "inject innovative DNA" into the country's large firms ...

South Korean stocks finished higher Wednesday, as investors picked up big-cap tech shares amid caution ahead of high-stakes talks with the United States on its sweeping tariff scheme. The local ...